These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of lamotrigine in juvenile myoclonic epilepsy. Buchanan N. Seizure; 1996 Jun; 5(2):149-51. PubMed ID: 8795132 [Abstract] [Full Text] [Related]
4. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Wallace SJ. Epilepsy Res; 1998 Jan; 29(2):147-54. PubMed ID: 9477147 [Abstract] [Full Text] [Related]
10. Epilepsy with myoclonic absences: Electroclinical characteristics in a distinctive pediatric epilepsy phenotype. Zanzmera P, Menon RN, Karkare K, Soni H, Jagtap S, Radhakrishnan A. Epilepsy Behav; 2016 Nov 06; 64(Pt A):242-247. PubMed ID: 27770719 [Abstract] [Full Text] [Related]
11. Worsening of negative myoclonus by lamotrigine in a case of idiopathic focal epilepsy of children with long-term follow-up. Gélisse P, Genton P, Velizarova R, Serafini A, Crespel A. Brain Dev; 2012 Mar 06; 34(3):248-50. PubMed ID: 21621357 [Abstract] [Full Text] [Related]
12. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy. Jozwiak S, Terczynski A. Seizure; 2000 Oct 06; 9(7):486-92. PubMed ID: 11034873 [Abstract] [Full Text] [Related]